JAGX.US Jaguar Animal Health Inc

Healthcare Pharmaceuticals USA Stocks
0.4188 USD
Close of Nov 15, 2026
0.3600 981.75
Market cap
USD 5.59M
P/E
-
P/B
0.84x
ROE
-123.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is JAGX.US undervalued?

Graham number

The Graham number of Jaguar Animal Health Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jaguar Animal Health Inc fundamental analysis

No fundamental analysis for Jaguar Animal Health Inc yet.

Jaguar Animal Health Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jaguar Animal Health Inc

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for th…

Full company profile